Last reviewed · How we verify
Ferrous sulfate 325mg
At a glance
| Generic name | Ferrous sulfate 325mg |
|---|---|
| Also known as | Active comparator |
| Sponsor | University of Colorado, Denver |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Early Antenatal Support for Iron Deficiency Anemia (PHASE4)
- Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia (PHASE3)
- Kids With Iron Deficiency and Scoliosis (NA)
- Intravenous Versus Oral Iron for Treating Iron-Deficiency Anemia in Pregnancy (PHASE3)
- Impact of Iron Supplementation on Right Ventricular Function and Exercise Performance in Hypoxia (EARLY_PHASE1)
- Treatment of Non-Anemic Iron Deficiency in Pregnancy (NA)
- Once Versus Twice Daily Iron Supplementation in Pregnant Women (NA)
- Intravenous Iron for Iron-deficiency Anemia in Pregnancy: a Randomized Controlled Trial (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Ferrous sulfate 325mg CI brief — competitive landscape report
- Ferrous sulfate 325mg updates RSS · CI watch RSS
- University of Colorado, Denver portfolio CI